Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 64

1.

Dynamics of reverse cholesterol transport: protection against atherosclerosis.

Sviridov D, Nestel P.

Atherosclerosis. 2002 Apr;161(2):245-54. Review.

PMID:
11888506
[PubMed - indexed for MEDLINE]
2.

High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport.

von Eckardstein A, Nofer JR, Assmann G.

Arterioscler Thromb Vasc Biol. 2001 Jan;21(1):13-27. Review.

PMID:
11145929
[PubMed - indexed for MEDLINE]
Free Article
3.

Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment.

Hersberger M, von Eckardstein A.

Drugs. 2003;63(18):1907-45. Review.

PMID:
12930163
[PubMed - indexed for MEDLINE]
4.

Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia.

Le Goff W, Guerin M, Chapman MJ.

Pharmacol Ther. 2004 Jan;101(1):17-38. Review.

PMID:
14729390
[PubMed - indexed for MEDLINE]
5.

Have we forgotten the pivotal role of high-density lipoprotein cholesterol in atherosclerosis prevention?

Wierzbicki AS.

Curr Med Res Opin. 2005 Feb;21(2):299-306. Review.

PMID:
15802001
[PubMed - indexed for MEDLINE]
6.

Cholesteryl ester transfer protein (CETP) inhibition beyond raising high-density lipoprotein cholesterol levels: pathways by which modulation of CETP activity may alter atherogenesis.

Klerkx AH, El Harchaoui K, van der Steeg WA, Boekholdt SM, Stroes ES, Kastelein JJ, Kuivenhoven JA.

Arterioscler Thromb Vasc Biol. 2006 Apr;26(4):706-15. Epub 2006 Jan 26. Review.

PMID:
16439711
[PubMed - indexed for MEDLINE]
Free Article
7.

[High density lipoproteins (HDL). A therapeutic objective in the atherosclerosis prevention?].

Pérez-Méndez O.

Arch Cardiol Mex. 2004 Jan-Mar;74(1):53-67. Review. Spanish.

PMID:
15125268
[PubMed - indexed for MEDLINE]
8.

Pharmacologic elevation of high-density lipoproteins: recent insights on mechanism of action and atherosclerosis protection.

Meyers CD, Kashyap ML.

Curr Opin Cardiol. 2004 Jul;19(4):366-73. Review.

PMID:
15218398
[PubMed - indexed for MEDLINE]
9.

Determinants of plasma HDL concentrations and reverse cholesterol transport.

Lewis GF.

Curr Opin Cardiol. 2006 Jul;21(4):345-52. Review.

PMID:
16755204
[PubMed - indexed for MEDLINE]
10.

High-density lipoprotein cholesterol: a potential therapeutic target for prevention of coronary artery disease.

Chernobelsky A, Ashen MD, Blumenthal RS, Coplan NL.

Prev Cardiol. 2007 Winter;10(1):26-30. Review.

PMID:
17215630
[PubMed - indexed for MEDLINE]
11.

Apolipoprotein A-II, HDL metabolism and atherosclerosis.

Tailleux A, Duriez P, Fruchart JC, Clavey V.

Atherosclerosis. 2002 Sep;164(1):1-13. Review.

PMID:
12119188
[PubMed - indexed for MEDLINE]
12.

Current understanding of the metabolism and biological actions of HDL.

von Eckardstein A, Hersberger M, Rohrer L.

Curr Opin Clin Nutr Metab Care. 2005 Mar;8(2):147-52. Review.

PMID:
15716792
[PubMed - indexed for MEDLINE]
13.

HDL and inflammation in atherosclerosis.

Spieker LE, Ruschitzka F, Lüscher TF, Noll G.

Curr Drug Targets Immune Endocr Metabol Disord. 2004 Mar;4(1):51-7. Review.

PMID:
15032626
[PubMed - indexed for MEDLINE]
14.

Therapeutic interventions targeted at the augmentation of reverse cholesterol transport.

Toth PP, Davidson MH.

Curr Opin Cardiol. 2004 Jul;19(4):374-9. Review.

PMID:
15218399
[PubMed - indexed for MEDLINE]
15.

Reverse cholesterol transport in familial hypercholesterolemia.

Guerin M.

Curr Opin Lipidol. 2012 Aug;23(4):377-85. doi: 10.1097/MOL.0b013e328353ef07. Review.

PMID:
22510809
[PubMed - indexed for MEDLINE]
16.

[Regulation of serum HDL cholesterol and prevention of atherosclerosis].

Kahri J.

Duodecim. 2002;118(18):1863-71. Review. Finnish. No abstract available.

PMID:
12422668
[PubMed - indexed for MEDLINE]
17.

Reverse cholesterol transport and cholesterol efflux in atherosclerosis.

Ohashi R, Mu H, Wang X, Yao Q, Chen C.

QJM. 2005 Dec;98(12):845-56. Epub 2005 Oct 28. Review.

PMID:
16258026
[PubMed - indexed for MEDLINE]
Free Article
18.

High-density lipoproteins as therapeutic targets.

Nicholls SJ, Rye KA, Barter PJ.

Curr Opin Lipidol. 2005 Jun;16(3):345-9. Review.

PMID:
15891397
[PubMed - indexed for MEDLINE]
19.

In vivo macrophage-specific RCT and antioxidant and antiinflammatory HDL activity measurements: New tools for predicting HDL atheroprotection.

Escolà-Gil JC, Rotllan N, Julve J, Blanco-Vaca F.

Atherosclerosis. 2009 Oct;206(2):321-7. doi: 10.1016/j.atherosclerosis.2008.12.044. Epub 2009 Mar 21. Review.

PMID:
19362310
[PubMed - indexed for MEDLINE]
20.

Future therapeutic directions in reverse cholesterol transport.

Khera AV, Rader DJ.

Curr Atheroscler Rep. 2010 Jan;12(1):73-81. doi: 10.1007/s11883-009-0080-0. Review.

PMID:
20425274
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk